These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1137 related items for PubMed ID: 23861532
1. Undifferentiated spondyloarthritis vs ankylosing spondylitis and psoriatic arthritis: a real-life prospective cohort study of clinical presentation and response to treatment. Paramarta JE, De Rycke L, Ambarus CA, Tak PP, Baeten D. Rheumatology (Oxford); 2013 Oct; 52(10):1873-8. PubMed ID: 23861532 [Abstract] [Full Text] [Related]
2. Are ankylosing spondylitis, psoriatic arthritis and undifferentiated spondyloarthritis associated with an increased risk of cardiovascular events? A prospective nationwide population-based cohort study. Bengtsson K, Forsblad-d'Elia H, Lie E, Klingberg E, Dehlin M, Exarchou S, Lindström U, Askling J, Jacobsson LTH. Arthritis Res Ther; 2017 May 18; 19(1):102. PubMed ID: 28521824 [Abstract] [Full Text] [Related]
3. Psoriatic arthritis and spondyloarthritis assessment and management update. Mease P. Curr Opin Rheumatol; 2013 May 18; 25(3):287-96. PubMed ID: 23492739 [Abstract] [Full Text] [Related]
5. [Treatment of ankylosing spondylitis and undifferentiated spondyloarthritis with TNF alpha-antagonists]. Brandt J, Sieper J, Braun J. Z Rheumatol; 2003 Jun 18; 62(3):218-27. PubMed ID: 12827397 [Abstract] [Full Text] [Related]
6. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort. Ciurea A, Scherer A, Exer P, Bernhard J, Dudler J, Beyeler B, Kissling R, Stekhoven D, Rufibach K, Tamborrini G, Weiss B, Müller R, Nissen MJ, Michel BA, van der Heijde D, Dougados M, Boonen A, Weber U, Rheumatologists of the Swiss Clinical Quality Management Program for Axial Spondyloarthritis. Arthritis Rheum; 2013 Dec 18; 65(12):3096-106. PubMed ID: 23983141 [Abstract] [Full Text] [Related]
8. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi. Malaviya AN, Kalyani A, Rawat R, Gogia SB. Int J Rheum Dis; 2015 Sep 18; 18(7):736-41. PubMed ID: 26172961 [Abstract] [Full Text] [Related]
9. Efficacy and safety of adalimumab for the treatment of peripheral arthritis in spondyloarthritis patients without ankylosing spondylitis or psoriatic arthritis. Paramarta JE, De Rycke L, Heijda TF, Ambarus CA, Vos K, Dinant HJ, Tak PP, Baeten DL. Ann Rheum Dis; 2013 Nov 18; 72(11):1793-9. PubMed ID: 23139265 [Abstract] [Full Text] [Related]
11. Early tumor necrosis factor α antagonist therapy in everyday practice for inflammatory back pain suggesting axial spondyloarthritis: results from a prospective multicenter french cohort. Canouï-Poitrine F, Poulain C, Molto A, Le Thuaut A, Lafon C, Farrenq V, Ferkal S, Le Corvoisier P, Ghaleh B, Bastuji-Garin S, Fautrel B, Dougados M, Claudepierre P. Arthritis Care Res (Hoboken); 2014 Sep 18; 66(9):1395-402. PubMed ID: 24664935 [Abstract] [Full Text] [Related]
12. The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study. Lie E, Kristensen LE, Forsblad-d'Elia H, Zverkova-Sandström T, Askling J, Jacobsson LT, ARTIS Study Group. Ann Rheum Dis; 2015 Jun 18; 74(6):970-8. PubMed ID: 25710471 [Abstract] [Full Text] [Related]
13. Rituximab treatment for spondyloarthritis. A nationwide series: data from the AIR registry of the French Society of Rheumatology. Wendling D, Dougados M, Berenbaum F, Brocq O, Schaeverbeke T, Mazieres B, Marcelli C, Leparc JM, Bertin P, Robin M, Sibilia J, Lafforgue P, Prati C, Combe B, Gottenberg JE, French Society of Rheumatology and the Club Rhumatismes et Inflammation. J Rheumatol; 2012 Dec 18; 39(12):2327-31. PubMed ID: 22896028 [Abstract] [Full Text] [Related]
14. Successful short term treatment of patients with severe undifferentiated spondyloarthritis with the anti-tumor necrosis factor-alpha fusion receptor protein etanercept. Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Rudwaleit M, Sieper J, Braun J. J Rheumatol; 2004 Mar 18; 31(3):531-8. PubMed ID: 14994401 [Abstract] [Full Text] [Related]
15. [Axial spondyloarthritis and ankylosing spondylitis]. Nordström D, Kauppi M. Duodecim; 2010 Mar 18; 126(12):1467-74. PubMed ID: 20617750 [Abstract] [Full Text] [Related]
16. Performance of classification criteria for peripheral spondyloarthritis and psoriatic arthritis in the Leiden Early Arthritis cohort. van den Berg R, van Gaalen F, van der Helm-van Mil A, Huizinga T, van der Heijde D. Ann Rheum Dis; 2012 Aug 18; 71(8):1366-9. PubMed ID: 22504563 [Abstract] [Full Text] [Related]
17. Emerging drugs for the treatment of axial and peripheral spondyloarthritis. Braun J, Kiltz U, Heldmann F, Baraliakos X. Expert Opin Emerg Drugs; 2015 Mar 18; 20(1):1-14. PubMed ID: 25575936 [Abstract] [Full Text] [Related]
18. Ethnic influence in clinical and functional measures of Brazilian patients with spondyloarthritis. Skare TL, Bortoluzzo AB, Gonçalves CR, Braga da Silva JA, Ximenes AC, Bértolo MB, Ribeiro SL, Keiserman M, Menin R, Carneiro S, Azevedo VF, Vieira WP, Albuquerque EN, Bianchi WA, Bonfiglioli R, Campanholo C, Carvalho HM, Costa IP, Duarte AP, Gavi MB, Kohem CL, Leite NH, Lima SA, Meirelles ES, Pereira IA, Pinheiro MM, Polito E, Resende GG, Rocha FA, Santiago MB, Sauma Mde F, Sampaio-Barros PD. J Rheumatol; 2012 Jan 18; 39(1):141-7. PubMed ID: 22045839 [Abstract] [Full Text] [Related]
19. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis. van der Heijde D, Sieper J, Maksymowych WP, Dougados M, Burgos-Vargas R, Landewé R, Rudwaleit M, Braun J, Assessment of SpondyloArthritis international Society. Ann Rheum Dis; 2011 Jun 18; 70(6):905-8. PubMed ID: 21540200 [Abstract] [Full Text] [Related]